Cargando…

Metformin suppresses breast cancer growth via inhibition of cyclooxygenase-2

Pre-clinical and on-going trials have indicated the advantage of using metformin as an anticancer drug alone or in combination with other chemotherapeutics for the treatment of patients with breast cancer. However, the mechanisms by which metformin attenuates tumorigenesis remain to be further eluci...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Bin, Hu, Xinyu, He, Huimin, Fang, Wenzheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243079/
https://www.ncbi.nlm.nih.gov/pubmed/34257723
http://dx.doi.org/10.3892/ol.2021.12876

Ejemplares similares